Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimenAdolfo de Salazar, Julia Dietz, Velia Chiara di Maio, et al.
AIDS (London, England)|March 25, 2026
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIVMathieu Chalouni, Jessie Torgersen, Christopher T Rentsch, et al.
Joint Bone Spine|May 23, 2017
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritisMarco Sebastiani, Fabiola Atzeni, Laura Milazzo, et al.
The Journal of Trauma and Acute Care Surgery|March 10, 2020
Orthopedic injuries in patients with multiple injuries: Results of the 11th trauma update international consensus conference Milan, December 11, 2017Stefania Cimbanassi, Robert O'Toole, Marc Maegele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIVDaniela K van Santen, Mathieu Chalouni, Juan Berenguer, et al.
Viruses|May 25, 2024
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)Maria Giovanna Quaranta, Luisa Cavalletto, Francesco Paolo Russo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
Plos One|February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patientsLucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelMarkus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Infectious Diseases and Therapy|October 5, 2023
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled StudyLorenzo Piemonti, Giovanni Landoni, Antonio Voza, et al.
Pageof 24